Picture of Novelstem International logo

NSTM Novelstem International Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Novelstem International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.0090.0060.0530.0060
Net Total Accounts Receivable
Net Total Receivables0.01200.0110
Prepaid Expenses
Total Current Assets0.0370.0590.0870.0320.016
Long Term Investments
Long Term Notes Receivable
Total Assets2.612.292.250.160.016
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.1930.0650.3465.32.16
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.1930.3534.215.32.16
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity2.421.93-1.95-5.14-2.14
Total Liabilities & Shareholders' Equity2.612.292.250.160.016
Total Common Shares Outstanding